Rallybio Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	0.43	0.86	0.64	-	-	-
Revenue Growth	-35.61%	34.91%	-	-	-	-
Cost of Revenue	6.27	18.4	39.51	53.54	-	-
Gross Profit	-5.83	-17.54	-38.87	-53.54	-	-
Selling, General & Admin	16.09	13.83	18.33	25.39	27.2	18.74
Research & Development	-	-	-	-	40.69	26.91
Operating Expenses	16.09	13.83	18.33	25.39	67.88	45.65
Operating Income	-21.92	-31.36	-57.2	-78.93	-67.88	-45.65
Interest Expense	-	-	-	-	-	-0.01
Interest & Investment Income	2.45	2.19	4.22	6.15	1.96	0.05
Earnings From Equity Investments	-	-0.87	-2.24	-2.04	-1.08	-1.51
Other Non Operating Income (Expenses)	-	0.42	0.74	0.26	0.34	0.1
EBT Excluding Unusual Items	-19.47	-29.63	-54.48	-74.56	-66.65	-47.01
Merger & Restructuring Charges	47.7	-1.7	-3.3	-	-	-
Gain (Loss) on Sale of Investments	-	22.35	-	-	-	-
Pretax Income	28.21	-8.98	-57.78	-74.56	-66.65	-47.01
Income Tax Expense	1.4	-	-	-	-	-
Net Income	26.81	-8.98	-57.78	-74.56	-66.65	-47.01
Net Income to Common	26.81	-8.98	-57.78	-74.56	-66.65	-47.01
Net Income Growth	-	-	-	-	-	-
Shares Outstanding (Basic)	6	6	5	5	4	3
Shares Outstanding (Diluted)	6	6	5	5	4	3
Shares Change	2.81%	3.42%	7.66%	27.11%	24.70%	46.76%
EPS (Basic)	4.71	-1.59	-10.61	-14.75	-16.76	-14.74
EPS (Diluted)	4.65	-1.59	-10.61	-14.75	-16.76	-14.74
EPS Growth	-	-	-	-	-	-

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Free Cash Flow	30.99	-29.81	-49.28	-60.28	-57.34	-45.87
Free Cash Flow Per Share	5.38	-5.30	-9.05	-11.92	-14.41	-14.38
Operating Margin	-5050.92%	-3655.48%	-8993.08%	-	-	-
Profit Margin	6177.42%	-1046.39%	-9084.12%	-	-	-
Free Cash Flow Margin	7139.63%	-3474.71%	-7748.74%	-	-	-
EBITDA	-21.91	-31.27	-57.07	-78.78	-67.72	-45.54
D&A For EBITDA	0.01	0.09	0.13	0.15	0.17	0.11
EBIT	-21.92	-31.36	-57.2	-78.93	-67.88	-45.65
Revenue as Reported	0.43	0.86	0.64	-	-	-

SEC Filings: 10-K · 10-Q